Year-End Amendment

PHARMATHENE, INC for PHARMATHENE, INC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$180,000

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
Year-End Amendment (this page) Aug 6, 2007 $180,000 Replaced
Year-End Report Feb 11, 2008 $300,000 Yes

What was lobbied

One issue area, each in the filer's own words, with who lobbied on it and where.

Medical/Disease Research/Clinical Labs MED

S. 3678 Pandemic and All Hazards Preparedness Act now law - authorized advanced development funding for biodfense and infectious disease technologies. Plus-Up funding for our lead product Valortim.

LobbyistCovered position, as disclosed
FRANCESCA COOK N/A
MARK EDWARD COOKE N/A

Contacted: SENATE; Defense, Dept of (DOD); HOUSE OF REPRESENTATIVES; Health & Human Services, Dept of (HHS); Homeland Security, Dept of (DHS)

Bills named: S. 3678 (110th)

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.